Outcome of Board Meeting

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: November 3, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir / Madam, Sub: Outcome under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) for the meeting of Board of Directors of the Company held today on November 3, 2026. With reference to the captioned subject, we would like to inform that the Board of Directors of Amanta Healthcare Limited at its meeting held today, i.e. on Tuesday, November 3, 2026, have inter-alia considered and approved: 1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2026. (Copy is enclosed herewith) 2. Limited Review Report of the Auditors with unmodified opinion of the Company for the quarter and half year ended September 30, 2026. (Copy is enclosed herewith). The detailed disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith. The Meeting Commenced at 04:00 P.M. and concluded at 05:00 P.M. You are requested to take the same on your records. Thanking you, Yours faithfully, FOR, AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720